68 related articles for article (PubMed ID: 26132201)
1. Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
Dyhdalo KS; Ababneh E; Lanigan C; Bowers K; Zhang S; McKenney JK; Joehlin-Price AS
Int J Gynecol Pathol; 2023 Sep; 42(5):443-450. PubMed ID: 36731037
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers.
Gressel GM; Usyk M; Frimer M; Kuo DYS; Burk RD
PLoS One; 2021; 16(11):e0259188. PubMed ID: 34739493
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of p16 and COX-2 expression on the prediction of progression to endometrial cancer.
Kalkan HE; Akman L; Serin G; Terek MC; Zekioglu O; Ozsaran AA
Histol Histopathol; 2024 May; 39(5):565-571. PubMed ID: 37503793
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of FBXW7-mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target.
Urick ME; Bell DW
Cancer Med; 2020 Jun; 9(11):3863-3874. PubMed ID: 32248654
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of RHCG in endometrial cancer.
Wang H; Jin H; Zhao S
Histol Histopathol; 2024 May; 39(5):611-621. PubMed ID: 37732703
[TBL] [Abstract][Full Text] [Related]
6. [Clinical utility of serous tumoural markers].
Martín Suárez A; Alonso Díaz L; Ordiz Alvarez I; Vázquez J; Vizoso Piñeiro F
Aten Primaria; 2003; 32(4):227-39. PubMed ID: 12975087
[No Abstract] [Full Text] [Related]
7. Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal Cancer.
He R; Zhang H; Zhao H; Yin X; Lu J; Gu C; Gao J; Xu Q
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672336
[TBL] [Abstract][Full Text] [Related]
8. Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
Mori S; Gotoh O; Kiyotani K; Low SK
J Hum Genet; 2021 Sep; 66(9):853-868. PubMed ID: 34092788
[TBL] [Abstract][Full Text] [Related]
9. Slow skeletal muscle troponin T, titin and myosin light chain 3 are candidate prognostic biomarkers for Ewing's sarcoma.
Deng Y; Xie Q; Zhang G; Li S; Wu Z; Ma Z; He X; Gao Y; Wang Y; Kang X; Wang J
Oncol Lett; 2019 Dec; 18(6):6431-6442. PubMed ID: 31807166
[TBL] [Abstract][Full Text] [Related]
10. Prediction of lymphovascular space invasion in endometrial cancer using the 55-gene signature selected by DNA microarray analysis.
Watanabe T; Honma R; Kojima M; Nomura S; Furukawa S; Soeda S; Watanabe S; Fujimori K
PLoS One; 2019; 14(9):e0223178. PubMed ID: 31557240
[TBL] [Abstract][Full Text] [Related]
11. Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges.
Dong P; Xiong Y; Yue J; J B Hanley S; Kobayashi N; Todo Y; Watari H
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781521
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma.
Mhawech-Fauceglia P; Walia S; Yessaian A; Machida H; Matsuo K; Lawrenson K
Pathology; 2018 Aug; 50(5):499-503. PubMed ID: 29891190
[TBL] [Abstract][Full Text] [Related]
13. Troponin through the looking-glass: emerging roles beyond regulation of striated muscle contraction.
Johnston JR; Chase PB; Pinto JR
Oncotarget; 2018 Jan; 9(1):1461-1482. PubMed ID: 29416706
[TBL] [Abstract][Full Text] [Related]
14. Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas: A case report and literature review.
Xiu XX; Wang HL; Yun-Yi L; Fan-Dou K; Jin-Ping H
Medicine (Baltimore); 2017 Dec; 96(49):e8928. PubMed ID: 29245257
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and survival results in serous endometrium carcinoma and subgroup analysis for mixed serous and pure serous histology.
Kaban A; Topuz S; Sözen H; Minareci Y; Salihoğlu Y
J Turk Ger Gynecol Assoc; 2018 Mar; 19(1):23-28. PubMed ID: 29072180
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Study of ER, PR, Ki67 and p53 in Endometrial Hyperplasias and Endometrial Carcinomas.
Masjeed NMA; Khandeparkar SGS; Joshi AR; Kulkarni MM; Pandya N
J Clin Diagn Res; 2017 Aug; 11(8):EC31-EC34. PubMed ID: 28969139
[TBL] [Abstract][Full Text] [Related]
17. Factors prognostic of survival in advanced-stage uterine serous carcinoma.
Holman LL; Pal N; Iglesias DA; Soliman PT; Balakrishnan N; Klopp A; Broaddus RR; Fleming ND; Munsell MF; Lu KH; Westin SN
Gynecol Oncol; 2017 Jul; 146(1):27-33. PubMed ID: 28465008
[TBL] [Abstract][Full Text] [Related]
18. Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium.
Lawrenson K; Pakzamir E; Liu B; Lee JM; Delgado MK; Duncan K; Gayther SA; Liu S; Roman L; Mhawech-Fauceglia P
PLoS One; 2015; 10(7):e0130909. PubMed ID: 26132201
[TBL] [Abstract][Full Text] [Related]
19. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
